February 09, 2021 – Funding
The Lymphoma & Myeloma Program of the Dana Farber/Harvard Cancer Center seeks applications for a Career Enhancement Award in Myeloma Research. Funding has been provided through a grant from the National Cancer Institute...
February 04, 2021 – Announcements
This is a live event moderated by FOX Sports Senior Correspondent Pam Oliver and featuring four-time Olympian and breast cancer survivor Chaunté Lowe; basketball Hall of Famer and humanitarian Dikembe Mutombo; and cancer...
February 02, 2021
The Health Communication Core is working with DF/HCC investigators to pivot recruitment efforts into online channels, submit innovative grant applications, and enhance new models of patient care.
January 27, 2021
The recorded videos for the 8th Annual DF/HCC Celebration of Early Career Investigators in Cancer Research Symposium, which was held virtually on January 21, 2021, are now available.
January 25, 2021 – COVID-19
Whenever possible, we want to allow research participants to be vaccinated against COVID-19, if they choose to do so, and minimize any impact on their research participation. To that end, if the research protocol is...
January 25, 2021 – PRMS
The workflow for the NPA has been updated. This does not impact the workflows for Non-Human Subject Research, Secondary Use, Medical Record Review, or Non-Interventional Social Behavioral and Educational Research (SBER)...
January 21, 2021 – Announcements
Early career investigators are a unique reservoir of new ideas, innovation, and excellence in cancer research. To celebrate this, we welcome you to join the 8th Annual DF/HCC Celebration of Early Investigators in Cancer...
January 19, 2021 – Announcements
Dr. Kanarek joins DF/HCC as a member of the Leukemia Program.
December 30, 2020 – Funding
The National Cancer Institute (NCI) is providing an opportunity for supplemental funding to support exploratory research studies to expand the current understanding of cancer stigma, assess its impact on cancer control...
December 30, 2020 – Funding
A funding opportunity previously limited to DFCI investigators (the Dana-Farber/Novartis Drug Discovery & Translational Research Program, DDTRP) will soon open to all independent investigators at DF/HCC member...
The DF/HCC Connect:Science seminar series offers remote participation through Zoom to pull our community of faculty, trainees, and lab staff together during this difficult time and it promotes engagement during these next several weeks.
DF/HCC’s Center for Cancer Equity and Engagement is working to bring DF/HCC research and communities together to eliminate cancer disparities in Massachusetts.
This is a collaboration between Dana-Farber/Harvard Cancer Center and the David H. Koch Institute for Integrative Cancer Research, designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care.
